Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 108 Ovarian Neoplasms 64 Neoplasms 61 Fallopian Tube Neoplasms 40 Lung Neoplasms 37 Breast Neoplasms 33 Neoplasm Metastasis 25 Carcinoma, Ovarian Epithelial 25 Triple Negative Breast Neoplasms 21 Small Cell Lung Carcinoma 20 Esophageal Neoplasms 19 Endometrial Neoplasms 19 Colorectal Neoplasms 15 Advanced Solid Tumors 14 Squamous Cell Carcinoma of Head and Neck 13 Lymphoma, Large B-Cell, Diffuse 13 Unspecified Adult Solid Tumor, Protocol Specific 12 Stomach Neoplasms 11 Melanoma 11 Central Nervous System Neoplasms 11 Uterine Cervical Neoplasms 10 Pancreatic Neoplasms 10 Astrocytoma 10 Neuroblastoma 9 Medulloblastoma 9 Head and Neck Neoplasms 9 Carcinoma 9 Urinary Bladder Neoplasms 8 Solid Tumors 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8

Interventions

Paclitaxel 1 NVP-BKM120 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Non-Small Cell Lunch Cancer × Carboplatin × Clear all

NCT01820325 2018-10-11

BASALT-2

Novartis

Phase 1 Terminated

Non-Small Cell Lunch Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡